BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35120552)

  • 1. GnRH antagonist weakens endometrial stromal cells growth ability by decreasing c-kit receptor expression.
    Xu DF; Liu PP; Fan L; Xie Q; Zhang ZQ; Wang LQ; Wu QF; Tan J
    Reprod Biol Endocrinol; 2022 Feb; 20(1):29. PubMed ID: 35120552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol.
    Zhang J; Sun YF; Xu YM; Shi BJ; Han Y; Luo ZY; Zhao ZM; Hao GM; Gao BL
    Front Endocrinol (Lausanne); 2021; 12():578783. PubMed ID: 34079517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased AIF-1-mediated TNF-α expression during implantation phase in IVF cycles with GnRH antagonist protocol.
    Xu B; Zhou M; Wang J; Zhang D; Guo F; Si C; Leung PCK; Zhang A
    Hum Reprod; 2018 Jul; 33(7):1270-1280. PubMed ID: 29897458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of growth hormone on IVF/ICSI outcomes and endometrial receptivity of patients undergoing GnRH antagonist protocol with fresh embryo transfer: a pilot study.
    Chu Y; Wang L; Xie J; Yang S; Liu S; Hu D; Yue J
    Front Endocrinol (Lausanne); 2023; 14():1225121. PubMed ID: 37727454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the motility of human decidual endometrial stromal cells: possible effect on embryo implantation and pregnancy.
    Wu HM; Huang HY; Lee CL; Soong YK; Leung PC; Wang HS
    Biol Reprod; 2015 Apr; 92(4):98. PubMed ID: 25761596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH antagonist alters the migration of endometrial epithelial cells by reducing CKB.
    Chen Q; Fan Y; Zhou X; Yan Z; Kuang Y; Zhang A; Xu C
    Reproduction; 2020 May; 159(6):733-743. PubMed ID: 32213653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China.
    Yang J; Zhang X; Ding X; Wang Y; Huang G; Ye H
    Reprod Biol Endocrinol; 2021 Aug; 19(1):124. PubMed ID: 34384445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of S100P induces apoptosis in endometrial epithelial cell during GnRH antagonist protocol.
    Zhang D; Han M; Zhou M; Liu M; Li Y; Xu B; Zhang A
    Reprod Biol Endocrinol; 2021 Jul; 19(1):99. PubMed ID: 34215278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in humans: protocol effects.
    Haouzi D; Assou S; Dechanet C; Anahory T; Dechaud H; De Vos J; Hamamah S
    Biol Reprod; 2010 Apr; 82(4):679-86. PubMed ID: 20042535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hCG activates Epac-Erk1/2 signaling regulating Progesterone Receptor expression and function in human endometrial stromal cells.
    Tapia-Pizarro A; Archiles S; Argandoña F; Valencia C; Zavaleta K; Cecilia Johnson M; González-Ramos R; Devoto L
    Mol Hum Reprod; 2017 Jun; 23(6):393-405. PubMed ID: 28333280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frozen-thawed cleavage-stage embryo transfer cycles after previous GnRH agonist or antagonist stimulation.
    Bahçeci M; Ulug U; Erden HF; Tosun S; Ciray N
    Reprod Biomed Online; 2009 Jan; 18(1):67-72. PubMed ID: 19146771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles.
    Lai Q; Zhang H; Zhu G; Li Y; Jin L; He L; Zhang Z; Yang P; Yu Q; Zhang S; Xu JF; Wang CY
    Int J Clin Exp Pathol; 2013; 6(9):1903-10. PubMed ID: 24040457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.
    Wu L; Ren XL; Chen W; Huang B; Zhou YF; Jin L
    Curr Med Sci; 2019 Jun; 39(3):437-441. PubMed ID: 31209816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer.
    Ding X; Yang J; Li L; Yang N; Lan L; Huang G; Ye H
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):207. PubMed ID: 33711956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
    Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
    Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen-thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent implantation failure.
    Pan D; Yang J; Zhang N; Wang L; Li N; Shi J; Zhou H
    Reprod Biol Endocrinol; 2022 Feb; 20(1):26. PubMed ID: 35115007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of half-dose and full-dose GnRH antagonists on IVF-ET outcomes: a retrospective study.
    Zhao Y; Lian F; Xiang S; Yu Y; Pang C; Qiu Y
    BMC Pregnancy Childbirth; 2021 Oct; 21(1):727. PubMed ID: 34706665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.